Insights

For every brand, we use our network to uncover your customers’ mindsets, generating insights that matter.

Insights help brands thrive by continually shaping and adapting the conversation with all stakeholders, in a consistent, cohesive way.

What we do

How can Insights impact your business?

Insights tell the story behind the data – the challenges patients face around a condition, the outcomes HCPs identify as making a long-term difference and the patterns your field teams encounter. 

Understanding the dynamics and demographics of your disease area, and how your therapy and its treatment strategy directly improves lives, will reveal how to differentiate your brand and help to define a unique, memorable approach to your pharma communications. At this stage, we look at:

  • Ad boards
  • Competitor research 
  • Market research 
  • Conference attendance
  • KOL sentiment 
  • Sales representative feedback 
  • Scientific data analysis
  • Patient forum research 
  • Media updates 
  • Channel insights
  • Veeva CRM/Platform Data Analysis
  • HES Data
  • And more…

The Process

Establishing the foundations for your brand’s core messages.

Our team will dig into a number of information sources to uncover the mindsets, medical issues and approaches we need to understand in order to establish a context for your brand and develop a new conversation around its applications and benefits. 

We show sensitivity towards important data, respected professionals and individuals in the course of gaining insights to help us to create Pharmacohesion®.

Market research

We perform an in-depth study, looking at industry reviews, existing advertising, brand insights, scientific data and the media, as well as your competitors, in order to get a complete picture of the market and the angles or needs that are not currently addressed. If needed, we conduct our own KOL and patient research, either virtually or in person.

Frontline feedback

We’ll spend time talking to HCPs, patients, carers and also your customer-facing teams, soliciting feedback from the people directly invested in the outcomes around your therapy to obtain a thorough understanding of what matters most and what may be missing.

Identifying KOLs

To initiate debate, discussion and ongoing insights, we’ll assemble an advisory board of scientists and experts who can provide further in-depth knowledge of industry news and trends, and act as ongoing advisors and supporters of your brand’s objectives.

HES data from Meditrends

Meditrends is a bespoke database and analytical service, providing an invaluable resource for any NHS or pharmaceutical professional wishing to understand more about the demographics of their disease area. Without knowing when and how patients present at hospital with a particular condition, efforts at planning for resource allocation, for example, often involve guesswork. Instead, Dice and Meditrends can give you invaluable insights that you KNOW are based on reality.

Insights Icon

Insights

We take the time to thoroughly explore your therapy and your market, researching your customers’ mindsets and issues to uncover insights that matter.

Strategy Icon

Strategy

Armed with our insights, we assess your brand’s positioning, forming a precise differentiation strategy based on an in-depth understanding of the market situation.

Execution Icon

Execution

Pharmacohesion® delivers impactful, strategically-aligned tactical initiatives across all channels, both online and in print, working to meaningfully capture and convey your brand concept.

Measurement Icon

Measurement

Continued rigorous analysis throughout your campaign helps us to gauge reaction, refine our approaches and measure success, revealing Pharmacohesion®’s ROI.

How our clients have benefitted from the Insights approach

Leber’s Hereditary Optic Neuropathy (LHON)

Raising awareness from a standing start: a case study of our work in rare diseases

One of the greatest challenges with any rare disease is diagnosis. Understandably, clinicians are often unaware of diseases that they may only encounter once or twice in their whole careers.

Our client faced this exact challenge with Leber’s Hereditary Optic Neuropathy (LHON). This extremely rare mitochondrial disorder is difficult to diagnose – typically found in males aged 15-35, its only symptom is painless central vision loss in one eye, which often results in blindness. With prevalence in Europe of only ~2.2/100,000, it’s incredibly unlikely that an ophthalmologist will even encounter one patient their whole professional life.

To help the client sell its treatment to clinicians, we created an effective disease awareness campaign that would eventually dovetail with a brand launch. This ensured that clinicians could identify both the symptoms and solution as soon as the treatment was approved.

contact us meet the team